Abstract: Disclosed is an experimental device for studying the sediment yield behavior and the radial deformation of porous media during the exploitation of natural gas hydrates, comprising a high-pressure reactor, a hydrate sample chamber, a simulated wellbore, a deformation measurement unit, an ambient temperature control unit, an outlet control unit, an inlet control unit and a data processing unit. Further disclosed is a method using the above-mentioned experimental device to carry out experiments.

Abstract: An AC excitation synchronous condenser and a control method, an AC-excitation induction machine, a full-controlled AC excitation converter, a grid-side converter and a controller. The AC-excitation induction machine is the core power converting device, and its stator and rotor windings are AC windings with terminals. The controller is configured to control the full-controlled AC excitation converter to perform excitation and speed regulation on the AC-excitation induction machine and also control the grid-side converter to ensure the excitation capability of the full-controlled AC excitation converter, so that support and regulation of the active power and reactive power are achieved.

Abstract: The present invention discloses an image anti-aliasing system, which comprises an edge detection unit, a directional filter, a low-angle directional filter, a directional filtering fusion unit and a result fusion unit; the edge detection unit outputs the edge direction and edge confidence according to an input image, the directional filter outputs a directional filtering result based on the input image and the edge direction, the low-angle directional filter outputs a low-angle directional filtering result according to the input image and the edge direction; the directional filtering fusion unit weights and combines the result output from the directional filter and the result output from the low-angle directional filter according to the edge direction, and outputs a result of weighted combination of two directional filtering results; the result fusion unit outputs an optimized image according to the edge confidence, the input image and the result of the directional filtering fusion unit.

Abstract: A neural probe structure includes a probe which is inserted into a living body, and a magnetic field inductor which is formed in the probe, wherein when a power source is supplied, the magnetic field inductor generates a magnetic field and applies magnetic stimulation to a target site of the living body into which the probe is inserted. A method for manufacturing the neural probe structure includes forming a first pattern on a first substrate and filling the first pattern with a conductor, stacking a second substrate on the first substrate, and forming a second pattern connected to the first pattern on the second substrate and filling the second pattern with a conductor, wherein the first substrate and the second substrate form the probe, and the conductor of the first pattern and the conductor of the second pattern form the magnetic field inductor.

Abstract: An implant is described for anterior insertion in the spine. The implant includes a body and a cover, which house one or two blades attached to a blade actuating component. Each blade engages a corresponding channel in the blade actuating component. The blade or blades are extended or retracted when the blade actuating component is driven proximally inward or distally outward. Each blade is reinforced by a bridge portion formed along the distal facing side of the blade.

Abstract: Methods are provided for diagnosing, detecting, or prognosticating a GEP-NEN based on the expression level score of biomarkers exhibiting differential expression in subjects having a GEP-NEN relative to a reference or control sample. The invention also provides compositions and kits comprising these biomarkers and methods of using these biomarkers in subsets or panels thereof to diagnose, classify, and monitor GEP-NEN and types of GEP-NEN. The methods and compositions provided herein may be used to diagnose or classify a subject as having a GEP-NEN, to distinguish between different stages of GEP-NENs, e.g., stable or progressive, to provide a measure of risk of developing a progressive GEP-NEN, and to gauge the completeness of treatments for GEP-NEN including, but not limited to surgery and somatostatin therapy.

Abstract: An apparatus, system and process for utilizing dual complementary pattern illumination of a scene when performing depth reconstruction of the scene are described. The method may include projecting a first reference image and a complementary second reference image on a scene, and capturing first image data and second image data including the first reference image and the complementary second reference image on the scene. The method may also include identifying features of the first reference image from features of the complementary second reference image. Furthermore, the method may include performing three dimensional (3D) scene reconstruction for image data captured by the imaging device based on the identified features in the first reference image.

Abstract: The present application relates to a method for the preparation of a nanosuspension comprising nanoparticles of at least one natural material and an extract of at least one natural material, wherein the method comprises the steps of providing particles of at least one natural material having a particle size (D100) of less than 320 ?m; providing an extract of at least one natural material; dispersing said particles of at least one natural material and said extract of at least one natural material in a solvent; and milling the dispersion to a particle size (D90) of below 1000 nm (D90<1000 nm). Furthermore, the present application also relates to a nanosuspension prepared according to said method, and the use of such nanosuspension for the preparation of a medicament and/or nutritional supplement.

Abstract: Culture medium devices and systems are shown and described. In one embodiment a growth plate includes an upper surface, a recessed well, a raised platform having an opposing cavity, and raised extensions having an opposing receiving aperture. Typically, the well is recessed below the top surface and the platform is above the upper surface. A growth plate assembly typically includes at least a first growth plate's raised stacking surfaces being temporarily received by a second growth plate's receiving surfaces, thereby temporarily securing growth plates together.

Abstract: Nutritional supplements comprising individual quantities of turmeric, Peganum harmala, and Arum palaestinum are provided, which promote several aspects of human health. Advantageously, the turmeric is present in an amount greater than that of Peganum harmala or Arum palaestinum, and the supplements may contain additional beneficial ingredients, such as ?-sitosterol, vanillin, garlic, and Vitamin C.

Abstract: A semiconductor memory element is provided including a laminated structure, in which a memory member and a conductor are superposed on a semiconductor substrate. The memory member has a bottom surface in contact with the semiconductor substrate, an upper surface in contact with the conductor, and side surfaces, which are in contact with and surrounded by a partition wall; the bottom surface of the memory member has a width of equal to or not more than 100 nm; a shortest distance between the conductor and the semiconductor substrate is twice or more of the width of the bottom surface of the memory member; the side surface of the memory member has a width, which is either the same as the width of the bottom surface and constant at any position above the bottom surface, or the widest at a position other than the bottom surface and above the bottom surface.

Abstract: Compositions having low quantities of volatile organic compounds (VOCs) and uses thereof are generally disclosed. In some embodiments, the compositions are aqueous compositions, such as aqueous suspensions, suitable for use as coating or paint compositions. In some embodiments, the compositions are aqueous compositions that include, among other components, a film-forming polymer and a coalescing aid. In some embodiments, the coalescing aids are derived from a renewable feedstock. Methods and systems for making such compositions are also disclosed. Novel coalescing aids are also disclosed.

Abstract: Methods and systems are provided to monitor bio-signals associated with one or more physiological structures of a subject, process the bio-signals to determine neural information, determine a current state of the subject based on the neural information, determine feedback to be provided to the subject based on the current neural state and a desired neural state, and/or to provide the feedback to the subject in order to modify the subject's current neural state to the desired neural state. The neural information may include validated neural indices relating to dynamic regulation of the monitored physiological structures via identifiable neural pathways and/or neural metrics quantified from such neural indices.

Abstract: A composition comprising microcapsules, the microcapsules containing both live mammalian ovarian granulosa cells and live mammalian ovarian theca cells, is described. In some embodiments, the granulosa cells and the theca cells are contained in separate microcapsules in the composition; in some embodiments, the granulosa cells and the theca cells are contained together in the same microcapsules in the composition. The composition is can be used for estrogen, and optionally also progesterone, delivery, and hence is preferably free or essentially free of oocytes. Methods of using the same and pharmaceutical formulations containing the same are also described.

Abstract: Compositions including a therapeutically effective amount of an HIV immunogen in combination with an agent that stimulates the Ras pathway, wherein the agent is not an aluminum salt, are disclosed. Methods are also disclosed for inducing an immune response to HIV, and/or to inhibit or treat HIV infection, in a subject, using an HIV immunogen and an agent that stimulates the Ras pathway. Methods also are disclosed for determining if an immunogenic composition will induce a protective response, and/or to determine if an immunogenic composition is of use to prevent or treat an HIV infection. The methods including determining if the immunogenic composition increases the level of one or more components of the Ras signaling pathway.

Abstract: Systems and methods include: implementing a first machine learning model to generate an output of a global digital threat score for an online activity based on an input of the collected digital event data; implementing a second machine learning model that generates a category inference of a category of digital fraud or a category of digital abuse from a plurality of digital fraud or digital abuse categories; selecting a third machine learning model from an ensemble of digital fraud or digital abuse machine learning models based on the category inference generated by the second machine learning model, wherein the ensemble of digital fraud or digital abuse machine learning models comprise a plurality of disparate digital fraud or digital abuse category-specific machine learning models; and implementing the selected third machine learning model to generate a digital fraud or digital abuse category-specific threat score based on the digital event data.

Abstract: The antimicrobial agent includes at least one two-dimensional metal carbide layer. The two-dimensional metal carbide has the formula Tin+1CnTx, where T represents a terminal functional group and x represents the number of terminal functional groups. The two-dimensional metal carbide is preferably Ti3C2Tx. The terminating group may be oxygen, hydroxide (OH), fluorine or combinations thereof. The antimicrobial agent may be used as a two-dimensional metal carbide antimicrobial membrane (10) or filter for removal of harmful bacteria, such as E. coli and B. subtilis. A stack of two-dimensional metal carbide layers (14) may be supported on a polymer filter substrate (12), such as a polyvinylidene fluoride (PVDF) supporting substrate.

Abstract: A Chromatography system that includes a microfluidic device configured to provide three-way switching or switching between three or more inputs or outputs. The microfluidic device fluidically coupled to one or more switching valves to provide for selective control of fluid flow in the chromatography system.